Vitadio

Vitadio is on a mission to empower people to take control of their health with digital technology. The medtech company develops prescription digital therapeutics for cause-oriented treatment of lifestyle-related conditions. The company’s app for iOS and Android is approved for support in the treatment of type 2 diabetes and is fully covered by health insurers in Germany. In the Czech Republic, Vitadio’s products are used by pharmaceutical companies as a drug companion app. Vitadio was started in 2019 by 4 founders. Jan Šomvársky is the CEO, Boleslav Kristián and Ondřej Kulatka are the leaders of product and technical development. Lenka Röhryová completes the team as a Chief Scientific Officer. The international team in Vitadio consists of 40 people across offices in Prague and Berlin. Vitadio plans to launch new therapies and internationalize to fuel its vision to help patients live free of chronic conditions.